Specializing in small-molecule drug discovery, the focus is on developing compounds that target RNA biology, aiming to unlock new therapeutic possibilities for diseases by addressing previously “undruggable” targets. A collaborative scientific team drives efforts to innovate and expand the potential of RNA in medicine.